Using CPAP to treat high blood pressure in patients with autonomic failure
Official title: Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension
Run by Vanderbilt University Medical Center · NCT05489575 · Data updated 2026-11-12
This study tests if using a CPAP machine can help people with autonomic failure lower their nighttime blood pressure when they lie down.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 80 Years |
| Sex | All |
| Enrollment | 59 (estimated) |
| Sponsor | Vanderbilt University Medical Center Academic / other |
| Locations | 1 site (Nashville, Tennessee) |
| Status | Recruiting |
| Started | June 23, 2022 |
| Main results expected | March 1, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | April 7, 2026 |
| Trial ID | NCT05489575 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40-80 with autonomic failure conditions such as pure autonomic failure, multiple system atrophy, or Parkinson disease who experience nocturnal supine hypertension.
✕Probably not a fit
Patients with recent facial trauma, intolerance to CPAP, or those who are bedridden may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of continuous positive airway pressure (CPAP) on individuals with autonomic failure who experience high blood pressure while lying down, known as supine hypertension. Participants will undergo a series of tests at the Vanderbilt Clinical Research Center, including both daytime and overnight assessments with active and sham CPAP treatments. The study aims to determine if CPAP can effectively lower nighttime blood pressure in these patients. Measurements will include blood pressure, heart rate, and other cardiovascular parameters during the interventions.
Why it matters
Potential benefit: If successful, this approach could provide a new treatment option for managing high blood pressure in patients with autonomic failure.
How similar studies have gone: While the use of CPAP is well-established for sleep apnea, its application for treating supine hypertension in autonomic failure is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female subjects, age 40-80 years, with autonomic failure including pure autonomic failure, multiple system atrophy and Parkinson disease. * Neurogenic orthostatic hypotension, defined as a ≥20-mmHg decrease in systolic blood pressure within 3 minutes of standing associated with impaired autonomic reflexes determined by autonomic testing in the absence of other identifiable causes. * Nocturnal supine hypertension (nighttime systolic blood pressure ≥140 mmHg) during the overnight screening for supine hypertension. * Patients who are willing and able to provide informed consent Exclusion Criteria: * Patients with history of recent facial trauma or surgery or intolerance to CPAP or to the CPAP mask. * Patients who cannot tolerate the medication withdrawal, defined as those who are unable to stand for at least one minute or those with sustained supine blood pressure ≥180/110 mmHg after the medication withdrawal period. * Bedridden patients or those who are unable to stand due to motor impairment or severe orthostatic hypotension. * Smokers, patients who are pregnant, or have clinically unstable coronary artery disease, or major cardiovascular or neurological event in the past 6 months; heart failure; and other factors which in the investigator's opinion would prevent the subject from completing the protocol including clinically significant abnormalities in clinical or laboratory testing.
Where it's running
-
Autonomic Dysfunction Center/ Vanderbilt University Medical Center
Nashville, Tennessee, United States Recruiting
Study contacts
- Principal investigator: Italo Biaggioni, MD — Vanderbilt University Medical Center
- Study coordinator: Bonnie K Black, RN, NP
- Email: bonnie.black@vumc.org
- Phone: 615-343-6862
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Imaging with [18F]F-DOPA in patients with autonomic failure
This study is testing a special imaging technique to see if it can help identify early signs of neurodegenerative diseases in people with autonomic failure.
-
Observing the progression of synucleinopathies
This study is tracking how synucleinopathies, a group of brain diseases, progress in adults with symptoms like dizziness when standing up to better understand their development over time.
-
Using an accelerometer to measure symptoms of neurogenic orthostatic hypotension
This study is testing if using a device to track how long people with neurogenic orthostatic hypotension can stay upright helps show if their medication works better than a placebo.
-
Heat application for managing high blood pressure in patients with autonomic failure
This study is testing if using a heating pad on the belly at night can help people with autonomic failure lower their high blood pressure while lying down.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
Collecting data on neurodegenerative diseases progression markers
This study is trying to find new signs that can help doctors understand how neurodegenerative diseases like Parkinson's progress, so they can improve early treatment options for patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.